Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Development of novel, daptomycin-inspired antimicrobial peptides using non-canonical amino acids

Award Number: R15AI188560
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/20/2024
PERIOD OF PERFORMANCE END DATE: 11/30/2027

Group Awards By:

View Award Description

Development of novel, daptomycin-inspired antimicrobial peptides using non-canonical amino acids - Abstract - Development of novel, daptomycin-inspired antimicrobial peptides using non-canonical amino acids The demand for novel antimicrobial compounds is a pressing challenge for society. However, due to bacterial resistance development and industrial challenges, the development of new antibacterial compounds has lagged far behind the current clinical needs. The proposed work aims to address this problem by developing novel, antimicrobial peptides based on an already clinically approved molecule, daptomycin, by improving the fundamental understanding of the sequence-structure-activity relationship and implementing this knowledge in novel molecules. Specifically, the goal is to develop peptide molecules which recapitulate the key components of daptomycin activity, i.e. calcium binding and lipid membrane disruption, while improving both the resistance to host degradation and synthetic processes required to create the molecules. This will be facilitated by incorporation of non-canonical amino acids into the novel sequences. Specifically, we will characterize the efficacy of novel peptides which mimic daptomycin’s calcium binding properties. The design of the peptides will start with a well characterized antimicrobial peptide and graft natural and de novo designed calcium binding sequences on to the backbone peptide. These experiments will entail the evaluation of antimicrobial activity using both laboratory and clinical isolate strains of bacteria. Using this information, we will investigate the response of different, clinically relevant bacteria to the peptides with the goal of optimizing efficacy. This will involve investigating bacterial transcriptional responses to the molecules and changes in membrane permeability. We will simultaneously characterize the biophysical properties of calcium binding and lipid interactions of the newly synthesized peptides. In parallel, we will also develop novel sequences that mimic the lipophilic tail of daptomycin, a key contributor to the membrane permeabilizing mechanism of action. These molecules will be characterized using similar approaches, with additional emphasis on evaluating the effects of these lipophilic modifications on peptide structure and aggregation in solution. We will screen a series of aromatic substitutions using non-canonical amino acids to improve protease resistance of the molecules. Finally, we will take the best performing sequences for calcium binding and membrane disruption and create and optimize hybrid peptides which can leverage the benefits realized in earlier stages. These sequences will be aggressively evaluated for efficacy against clinical isolates, potential for resistance development, and cytotoxicity in standard and co-culture models.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $474,363 )
2025	2025	ROWAN UNIVERSITY	201 MULLICA HILL RD	GLASSBORO	NJ	08028	GLOUCESTER	USA	Allergy and Infectious Diseases Research	000	1	12/20/2024	NEW	$474,363
														Subtotal = $474,363

Grand Total All Awards = $474,363

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Development of novel, daptomycin-inspired antimicrobial peptides using non-canonical amino acids

Award Number: R15AI188560

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/20/2024

PERIOD OF PERFORMANCE END DATE: 11/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer